Related Experiment Video
Updated: Sep 27, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Q61 mutant-mediated dynamics changes of the GTP-KRAS complex probed by Gaussian accelerated molecular dynamics and
Jianzhong Chen1, Qingkai Zeng1, Wei Wang1
1School of Science, Shandong Jiaotong University Jinan 250357 China chenjianzhong1970@163.com jzchen@sdjtu.edu.cn.
Abstract:
Understanding the molecular mechanism of the GTP-KRAS binding is significant for improving the target roles of KRAS in cancer treatment. In this work, multiple replica Gaussian accelerated molecular dynamics (MR-GaMD) simulations were applied to decode the effect of Q61A, Q61H and Q61L on the activity of KRAS. Dynamics analyses based on MR-GaMD trajectory reveal that motion modes and dynamics behavior of the switch domain in KRAS are heavily affected by the three Q61 mutants. Information of free energy landscapes (FELs) shows that Q61A, Q61H and Q61L induce structural disorder of the switch domain and disturb the activity of KRAS. Analysis of the interaction network uncovers that the decrease in the stability of hydrogen bonding interactions (HBIs) of GTP with residues V29 and D30 induced by Q61A, Q61H and Q61L is responsible for the structural disorder of the switch-I and that in the occupancy of the hydrogen bond between GTP and residue G60 leads to the structural disorder of the switch-II. Thus, the high disorder of the switch domain caused by three current Q61 mutants produces a significant effect on binding of KRAS to its effectors. This work is expected to provide useful information for further understanding function and target roles of KRAS in anti-cancer drug development.
Insights
Mutations in KRAS (Kirsten rat sarcoma viral oncogene homolog) at position 61 disrupt its switch domain, affecting GTP binding and potentially impacting cancer drug development.
Area of Science:
- Molecular Biology
- Biochemistry
- Computational Biology
Background:
- KRAS protein is a key regulator of cellular signaling pathways.
- Dysregulation of KRAS is implicated in numerous cancers.
- Understanding KRAS molecular mechanisms is crucial for targeted cancer therapies.
Purpose of the Study:
- To investigate the molecular impact of Q61 mutations (Q61A, Q61H, Q61L) on KRAS activity.
- To elucidate the effects of these mutations on GTP binding and effector interactions.
- To provide insights for developing novel KRAS-targeted anti-cancer drugs.
Main Methods:
- Multiple replica Gaussian accelerated molecular dynamics (MR-GaMD) simulations were employed.
- Analysis of simulation trajectories to study protein dynamics and conformational changes.
- Free energy landscape (FEL) calculations and interaction network analysis were performed.
Main Results:
- Q61A, Q61H, and Q61L mutations significantly alter the dynamics of the KRAS switch domain.
- These mutations induce structural disorder in the switch domain, impairing KRAS activity.
- Disruption of hydrogen bonding interactions with GTP is identified as a key mechanism.
Conclusions:
- The Q61 mutations destabilize KRAS-GTP binding by affecting crucial hydrogen bonds.
- Increased disorder in the switch domain impacts KRAS effector binding.
- Findings offer valuable information for KRAS-targeted anti-cancer drug discovery and development.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins,...
The Ras Gene
Ras is a...
Protein Dynamics in Living Cells
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...
MAPK Signaling Cascades
Activation and Inactivation of G Proteins

